Strategic Partnerships Telos Health operates within a broader Imperative Care ecosystem and collaborates with Proximie to develop the Telos robotic platform for remote and on-site stroke procedures, indicating opportunities to position integrated workflow and remote-capability solutions to hospitals and stroke centers.

Financial Backing Recent $100M convertible note financing signals strong investor confidence and potential for accelerated product development, enabling sales outreach to healthcare systems prioritizing innovative thromboembolic treatment technologies and expansion plans.

Clinical Validation Product launches such as Ikon 24 Pro Guidewire and Zoom 4S Catheter, along with presentations from key trials, suggest healthcare facilities are seeking next‑generation thrombectomy and aspiration solutions, presenting upsell and cross-sell opportunities for Telos related hardware and compatible platforms.

Executive Access New board appointment of an experienced medtech investor and CEO operates signals governance maturity and strategic direction, presenting a touchpoint for enterprise customers and procurement teams evaluating long‑term partnerships and capital expenditure planning.

Market Readiness Revenue in the low tens of millions and a focused product roadmap targeting stroke and pulmonary embolism interventions indicate a growing market segment receptive to integrated robotic and catheter-based systems, ideal for targeting mid‑size to large hospitals expanding neurovascular and interventional capabilities.